back to cluster viewer
cluster path 0001011110
52 words, 76,755 tokens
freq alpha suffix
Words in frequency order
1 | efficacy | 75,992
|
2 | efficacies | 630
|
3 | effectivity | 49
|
4 | bandgaps | 6
|
5 | hdhe-group | 5
|
6 | cytoarchitectonics | 4
|
7 | interzone | 4
|
8 | nanotoxicity | 4
|
9 | 4-methyl- | 3
|
10 | dose-effects | 3
|
11 | efficay | 3
|
12 | proposita | 3
|
13 | washability | 3
|
14 | autophage | 2
|
15 | dnak- | 2
|
16 | emot- | 2
|
17 | erysiphaceae | 2
|
18 | intersubjectivity | 2
|
19 | schistosomula | 2
|
20 | work-relatedness | 2
|
21 | 8.27- | 1
|
22 | abeta-reducing | 1
|
23 | ablasticity | 1
|
24 | anti-angiogenicity | 1
|
25 | anti-coagulability | 1
|
26 | azo- | 1
|
27 | bionomics | 1
|
28 | co2-balance | 1
|
29 | dominance-enhancing | 1
|
30 | duration/recovery | 1
|
31 | esterasic | 1
|
32 | foetotoxicity | 1
|
33 | forprevention | 1
|
34 | half-length | 1
|
35 | hiv-parameters | 1
|
36 | immunogenecity | 1
|
37 | inheritage | 1
|
38 | non-acidogenic | 1
|
39 | non-portability | 1
|
40 | pheno- | 1
|
41 | phyto-oestrogenic | 1
|
42 | sbccs | 1
|
43 | shadings | 1
|
44 | ssdna- | 1
|
45 | subselectivity | 1
|
46 | survival/fatality | 1
|
47 | template-dependent | 1
|
48 | toxico-pharmacokinetics | 1
|
49 | trifluorocompounds | 1
|
50 | trinitro | 1
|
51 | use-effectiveness | 1
|
52 | w90f | 1
|
Words in alphabetical order
1 | 4-methyl- | 3
|
2 | 8.27- | 1
|
3 | abeta-reducing | 1
|
4 | ablasticity | 1
|
5 | anti-angiogenicity | 1
|
6 | anti-coagulability | 1
|
7 | autophage | 2
|
8 | azo- | 1
|
9 | bandgaps | 6
|
10 | bionomics | 1
|
11 | co2-balance | 1
|
12 | cytoarchitectonics | 4
|
13 | dnak- | 2
|
14 | dominance-enhancing | 1
|
15 | dose-effects | 3
|
16 | duration/recovery | 1
|
17 | effectivity | 49
|
18 | efficacies | 630
|
19 | efficacy | 75,992
|
20 | efficay | 3
|
21 | emot- | 2
|
22 | erysiphaceae | 2
|
23 | esterasic | 1
|
24 | foetotoxicity | 1
|
25 | forprevention | 1
|
26 | half-length | 1
|
27 | hdhe-group | 5
|
28 | hiv-parameters | 1
|
29 | immunogenecity | 1
|
30 | inheritage | 1
|
31 | intersubjectivity | 2
|
32 | interzone | 4
|
33 | nanotoxicity | 4
|
34 | non-acidogenic | 1
|
35 | non-portability | 1
|
36 | pheno- | 1
|
37 | phyto-oestrogenic | 1
|
38 | proposita | 3
|
39 | sbccs | 1
|
40 | schistosomula | 2
|
41 | shadings | 1
|
42 | ssdna- | 1
|
43 | subselectivity | 1
|
44 | survival/fatality | 1
|
45 | template-dependent | 1
|
46 | toxico-pharmacokinetics | 1
|
47 | trifluorocompounds | 1
|
48 | trinitro | 1
|
49 | use-effectiveness | 1
|
50 | w90f | 1
|
51 | washability | 3
|
52 | work-relatedness | 2
|
Words in suffix order
1 | 8.27- | 1
|
2 | ssdna- | 1
|
3 | dnak- | 2
|
4 | 4-methyl- | 3
|
5 | pheno- | 1
|
6 | azo- | 1
|
7 | emot- | 2
|
8 | schistosomula | 2
|
9 | proposita | 3
|
10 | non-acidogenic | 1
|
11 | phyto-oestrogenic | 1
|
12 | esterasic | 1
|
13 | erysiphaceae | 2
|
14 | co2-balance | 1
|
15 | autophage | 2
|
16 | inheritage | 1
|
17 | interzone | 4
|
18 | w90f | 1
|
19 | dominance-enhancing | 1
|
20 | abeta-reducing | 1
|
21 | half-length | 1
|
22 | forprevention | 1
|
23 | trinitro | 1
|
24 | hdhe-group | 5
|
25 | sbccs | 1
|
26 | bionomics | 1
|
27 | cytoarchitectonics | 4
|
28 | toxico-pharmacokinetics | 1
|
29 | trifluorocompounds | 1
|
30 | efficacies | 630
|
31 | shadings | 1
|
32 | bandgaps | 6
|
33 | hiv-parameters | 1
|
34 | work-relatedness | 2
|
35 | use-effectiveness | 1
|
36 | dose-effects | 3
|
37 | template-dependent | 1
|
38 | efficay | 3
|
39 | efficacy | 75,992
|
40 | duration/recovery | 1
|
41 | immunogenecity | 1
|
42 | anti-angiogenicity | 1
|
43 | ablasticity | 1
|
44 | nanotoxicity | 4
|
45 | foetotoxicity | 1
|
46 | survival/fatality | 1
|
47 | washability | 3
|
48 | anti-coagulability | 1
|
49 | non-portability | 1
|
50 | effectivity | 49
|
51 | intersubjectivity | 2
|
52 | subselectivity | 1
|